Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies, and exploring their potential to provide a deep and durable, perhaps curative, treatment, for patients with B cell-mediated autoimmune diseases.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Steven Nichtberger,M.D.$616.1M
Market Cap • 07/05/20242017
(há 7 anos)
2019
(5 years ago)
NASDAQ
Listagem
Philadelphia
Sede • Pennsylvania60
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
CABASó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.